🔎 Trials Near Me

Hem › Alopecia areata › Indiana

Kliniska studier för Alopecia areata i Indiana

8 studier för Alopecia areata söker deltagare vid platser i Indiana.

Städer i Indiana

Officiell studietext (engelska)

A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata

  • Dawes Fretzin- Indianapolis /ID# 283498, Indianapolis
RekryterarFas 3
Ålder 6 till 17 · Alla kön · Uppdaterad 2 okt. 2026 · NCT07772492

A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata

  • Dawes Fretzin Clinical Research Group, LLC, Indianapolis
RekryterarFas 3
Ålder 12 och äldre · Alla kön · Uppdaterad 18 sep. 2026 · NCT06873945

HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata

  • Dawes Fretzin Clinical Research Group, Indianapolis
RekryterarFas 1
Ålder 18 till 70 · Alla kön · Uppdaterad 15 sep. 2026 · NCT07049328

A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata

  • Dawes Fretzin Clinical Research Group, LLC, Indianapolis
RekryterarFas 3
Ålder 12 och äldre · Alla kön · Uppdaterad 10 sep. 2026 · NCT07733765

A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata

  • Indiana University Health University Hospital /ID# 259827, Indianapolis
RekryterarFas 3
Ålder 12 till 63 · Alla kön · Uppdaterad 3 aug. 2026 · NCT06012240

A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.

  • Dawes Fretzin Clinical Research Group, LLC, Indianapolis
RekryterarFas 3
Ålder 6 till 14 · Alla kön · Uppdaterad 28 apr. 2026 · NCT07029828

A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ALD-102 Solution in Subjects With Alopecia Areata

  • Options Research Group, West Lafayette
RekryterarFas 1/2
Ålder 18 till 55 · Alla kön · Uppdaterad 4 mars 2026 · NCT06826196

Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata

  • Ds Research - Indiana, Clarksville
  • Dawes Fretzin Clinical Research Group Llc., Indianapolis
RekryterarFas 3
Ålder 12 till 17 · Alla kön · Uppdaterad 28 jan. 2026 · NCT07133308

Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.